PlainRecalls
FDA Drug Moderate Class II Terminated

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

Reported: October 30, 2019 Initiated: October 9, 2019 #D-0147-2020

Product Description

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

Reason for Recall

GMP Deviations: potential glass contamination

Details

Units Affected
1855 bags
Distribution
Nationwide.
Location
West Columbia, SC

Frequently Asked Questions

What product was recalled?
PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25. Recalled by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center. Units affected: 1855 bags.
Why was this product recalled?
GMP Deviations: potential glass contamination
Which agency issued this recall?
This recall was issued by the FDA Drug on October 30, 2019. Severity: Moderate. Recall number: D-0147-2020.